http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Boston Scientific Launches DIRECTSENSE™ Technology
-
Boston Scientific to Participate in Jefferies 2020 Healthcare Conference
-
Appaloosa's 13F Shows New Stakes in Goodyear (GT), Twitter (TWTR) (more..)
-
Boston Scientific (BSX) Announces Late-Breaking Clinical Trial Data Underscore Safety And Efficacy Of Boston Scientific S-ICD System
-
Late-Breaking Clinical Trial Data Underscore Safety And Efficacy Of Boston Scientific S-ICD System
-
PINNACLE FLX Study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device Presented as Late-Breaking Clinical Trial at HRS 2020 SCIENCE
-
Boston Scientific Announces May 2020 Virtual Conference Schedule
-
Boston Scientific Announces Results For First Quarter 2020
-
New Renewable Energy Agreements To Reduce Boston Scientific Carbon Footprint By Half
-
Boston Scientific Announces 2020 Annual Meeting of Stockholders Will Be Conducted in Virtual Format
-
Boston Scientific (BSX) expects first quarter revenue growth to be approximately flat to up slightly
-
Boston Scientific Provides Update on COVID-19 Impact and Response Efforts
-
Boston Scientific Announces February and March 2020 Conference Schedule
-
Boston Scientific Announces Results For Fourth Quarter And Full Year 2019
-
Boston Scientific (BSX) Reports Prelim. Q4 Sales of $2.9B
-
Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year 2019
-
Boston Scientific Announces January Conference Schedule and Conference Call Discussing Fourth Quarter 2019 Results
-
Boston Scientific (BSX) Granted FDA Clearance for EXALT Model D
-
Boston Scientific Receives FDA Clearance For World's First Single-Use Duodenoscope, EXALT™ Model D
-
AtriCure (ATRC) Appoints Karen Prange and Daniel Florin to Board
-
AtriCure Names Two Industry Veterans to Board of Directors
-
Boston Scientific to Participate in Evercore ISI and Piper Jaffray Healthcare Conferences
-
Boston Scientific (BSX) Reports Positive Data for Ranger Drug-Coated Balloon and the Eluvia Drug-Eluting Vascular Stent
-
Boston Scientific Announces Positive Data for the Ranger™ Drug-Coated Balloon and the Eluvia™ Drug-Eluting Vascular Stent at VIVA19
-
Boston Scientific Announces November 2019 Conference Schedule
-
Boston Scientific Announces Results For Third Quarter 2019
-
Boston Scientific Announces Conference Call Discussing Third Quarter 2019 Financial Results
-
Boston Scientific (BSX) Announces Positive Data from the EVOLVE Short DAPT study with the SYNERGY Bioabsorbable Polymer Stent
-
Boston Scientific Announces Positive Data from the EVOLVE Short DAPT study with the SYNERGY™ Bioabsorbable Polymer Stent
-
Boston Scientific Announces Scheduled Presentations at Transcatheter Cardiovascular Therapeutics 2019
-
Boston Scientific to Participate in the 2019 Wells Fargo Securities Healthcare Conference
-
Boston Scientific (BSX) Granted FDA Approval for ImageReady MRI Labeling for the Vercise Gevia
-
Boston Scientific Announces FDA Approval Of ImageReady™ MRI For Vercise Gevia™ Deep Brain Stimulation System
-
Boston Scientific Closes Acquisition of BTG plc.
-
Boston Scientific to Participate in 39th Annual Canaccord Genuity Growth Conference
-
Boston Scientific Announces Results For Second Quarter 2019
-
Boston Scientific Announces Conference Call Discussing Second Quarter 2019 Financial Results
-
Boston Scientific (BSX) Presents Strategies for Sustained Long-Range Growth Targets
-
Boston Scientific Presents Strategies for Sustained Long-Range Growth Targets at 2019 Investor Day
-
Boston Scientific Closes Acquisition Of Vertiflex, Inc.
-
Boston Scientific Initiates Trial Comparing Left Atrial Appendage Closure to Direct Oral Anticoagulants for Stroke Risk Reduction Post-AFib Ablation
-
Boston Scientific to Participate in Bernstein's 35th Annual Strategic Decisions Conference
-
Late-Breaking Trial Data Highlight Continued Clinical Success Of Boston Scientific EMBLEM™ S-ICD System
-
Boston Scientific (BSX) to Acquire Vertiflex for $465M Upfront Plus Contingent Payments
-
Boston Scientific Announces Agreement To Acquire Vertiflex, Inc.
-
Boston Scientific to Participate in the 2019 UBS Global Healthcare Conference
-
Boston Scientific (BSX) Receives U.S. FDA Approval for The VICI VENOUS STENT System
-
Boston Scientific Receives U.S. FDA Approval for The VICI VENOUS STENT™ System
-
Boston Scientific Announces Scheduled Presentations at Heart Rhythm 2019
-
Boston Scientific to Participate in Bank of America Merrill Lynch Healthcare Conference 2019

